Azithromycin: A new therapeutical strategy for acne in adolescents

Dermatology Online Journal

Volumn 13, Issue 4, 2007, Pages

  Bardazzi, Federico ^a   Savoia, Francesco ^a   Parente, Gianluca ^a   Tabanelli, Michela ^a   Balestri, Riccardo ^a   Spadola, Giuseppe ^a   Dika, Emi ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

AZITHROMYCIN; ANTIINFECTIVE AGENT;

ACNE; ACNE VULGARIS; ADOLESCENT; ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; HEARTBURN; HUMAN; MAJOR CLINICAL STUDY; MALE; NAUSEA; OPEN STUDY; PATIENT COMPLIANCE; PRESCRIPTION; SKIN INFLAMMATION; TREATMENT DURATION; TREATMENT RESPONSE; ADULT; AGED; MIDDLE AGED; TREATMENT OUTCOME;

ACNE VULGARIS; ADULT; AGED; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; FEMALE; HUMANS; MALE; MIDDLE AGED; TREATMENT OUTCOME;

EID: 36448948227     PISSN: None     EISSN: 10872108     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Herane MI, Ando I. Acne in infancy and acne genetics. Dermatology 2003, 206:24-28.
2. Leyden JJ. Therapy for acne vulgaris. N Engl J Med 1997, 336:1156-1162.
3. Leyden JJ. A review of the use of combination therapies for the treatment of acne vulgaris. J Am Acad Dermatol 2003, 49(Suppl 3):S200-S210.
4. Smolinski KN, Yan AC. Acne update: 2004.Curr Opin Pediatr. 2004 Aug;16(4):385-91.
5. Gollnick H, Cunliffe W, Berson D, et al. Management of acne: a report from a global alliance to improve outcomes in acne. J Am Acad Dermatol 2003, 49(Suppl 1):S1-37.
6. Tan AW, Tan HH. Acne vulgaris: a review of antibiotic therapy. Expert Opin Pharmacother. 2005 Mar;6(3): 409-18.
7. Duran JM, Amsden GW. Azithromycin: indications for the future? Expert Opin Pharmacother. 2000 Mar;1(3): 489-505.
8. Kapadia N, Talib A. Acne treated successfully with azithromycin. Int J Dermatol. 2004 Oct;43(10):766-7.
9. Caputo R, Barbareschi M, Veraldi S. Azithromycin: a new drug for systemic treatment of inflammatory acneic lesions. G Ital Dermatol Venereol. 2003;138:327-331.
10. Kus S, Yucelten D, Aytug A. Comparison of efficacy of azithromycin vs. doxycycline in the treatment of acne vulgaris. Clin Exp Dermatol. 2005 May;30(3):215-20.
11. Hardy DJ, Henesey DM, Beyer JM, et al. Comparative in vitro activities of new 14-, 15-, and 16-membered macrolides. Antimicrob Agents Chemother 1988; 32: 1710â€"1719.
12. Neu HC. Clinical microbiology of azithromycin. Am J Med 1991; 91 (Suppl. 3A): 12Sâ€"18S.
13. Witkowski JA, Parish LC. The assessment of acne: an evaluation of grading and lesion counting in the measurement of acne. Clin Dermatol. 2004 Sep-Oct;22(5):394-7
14. Finlay AY, Kahn GK. Dermatology Life Quality Index (DLQI): a simple practical measure for routine clinical use. Clin Exp Dermatol 1994; 19:210â€"6.
15. Barnes CJ, Eichenfield LF, Lee J, Cunningham BB. A practical approach for the use of oral isotretinoin for infantile acne. Pediatr Dermatol. 2005 Mar-Apr;22(2):166-9.
16. Brecher AR, Orlow SJ. Oral retinoid therapy for dermatologic conditions in children and adolescents. J Am Acad Dermatol 2003, 49:171-182.
17. Fernandez-Obregon AC. Azithromycin for the treatment of acne. Int J Dermatol. 2000 Jan;39(1):45-50.
18. Hopkins S. Clinical toleration and safety of azythromycin. Am J Med 1991; 91: 40Sâ€"5S.
19. Scheinfeld NS, Tutrone WD, Torres O, Weinberg JM. Macrolides in dermatology. Clin Derm 2003; 21: 40â€"9.
20. Alvarez-Elroco S, Enzler MJ. The macrolides. erythromycin, clarithromycin, and azithromycin. Mayo Clin Proc 1999; 74: 613†"34.
21. Ross JI, Snelling AM, Carnegie E, et al. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003, 148:467-478.
22. Rafiei R, Yaghoobi R. Azithromycin versus tetracycline in the treatment of acne vulgaris. J Dermatolog Treat. 2006;17(4):217-21.
23. Parsad D, Pandhi R, Nagpal R, Negi KS. Azithromycin monthly pulse vs daily doxycycline in the treatment of acne vulgaris. J Dermatol 2001; 28: 1â€"4.